APA (7th ed.) Citation

Z, C., W, L., C, L., J, C., X, T., C, Z., . . . M, Z. (2026). Exploratory study of PD-1 inhibitors with or without ruxolitinib for the treatment of adult EBV-associated hemophagocytic lymphohistiocytosis: A real-world data-based preliminary investigation. Clinical and experimental medicine, 26(1), . https://doi.org/10.1007/s10238-026-02136-0

Chicago Style (17th ed.) Citation

Z, Chen, Li W, Liu C, Chen J, Tan X, Zhou C, Li F, Lei P, and Zhou M. "Exploratory Study of PD-1 Inhibitors with or Without Ruxolitinib for the Treatment of Adult EBV-associated Hemophagocytic Lymphohistiocytosis: A Real-world Data-based Preliminary Investigation." Clinical and Experimental Medicine 26, no. 1 (2026). https://doi.org/10.1007/s10238-026-02136-0.

MLA (9th ed.) Citation

Z, Chen, et al. "Exploratory Study of PD-1 Inhibitors with or Without Ruxolitinib for the Treatment of Adult EBV-associated Hemophagocytic Lymphohistiocytosis: A Real-world Data-based Preliminary Investigation." Clinical and Experimental Medicine, vol. 26, no. 1, 2026, https://doi.org/10.1007/s10238-026-02136-0.